Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated Malignancies
| Image |  |
|---|---|
| Description | scientific article published on 13 September 2018 |
| Author/s |
author: Patrick Hwu |
| Publication date | September 13, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |